What the research firmly supports: BPC-157's gut healing, vascular, and neuroprotective mechanisms (strong preclinical evidence) Thymosin Alpha-1's immune modulating and T-cell restorative effects (strong preclinical + clinical evidence in viral disease) TB-500's cardiovascular repair and angiogenic properties (strong preclinical, early human data) What the research does not yet confirm: Randomised controlled trial data specifically in long COVID populations Optimal dosing, sequencing, and duration specifically for PASC Long-term safety data for extended post-viral use This doesn't mean these peptides don't work for long COVID
We look forward to continuing to engage with interested parties as these codes are billed, and we remain open to feedback on how to best value these codes in future rulemaking
August 23, 2021 Peterborough, New Hampshire defrauded of $2.3 million by cybercriminals Peterborough, New Hampshire, USA (Hillsborough County) The small town of Peterborough in the northeast of the USA has about 6300 inhabitants
ProHealth includes BPC-157 as a research-grade dietary ingredient for adults interested in supporting their general wellness.* The Science of Resilience- What Preclinical Research has Explored Animal model studies have investigated BPC-157 in connection with markers related to normal blood flow support, cellular maintenance, and a balanced inflammatory response within normal ranges.* Experimental cell and animal studies have also examined BPC-157 models related to: Normal muscle maintenance following physical activity* 1,3,10 Normal circulatory support for tissue nourishment* 2,4,6 Important: All cited research reflects preclinical findings from animal and cell studies
